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Background/aim: Oxidative stress contributes to pathophysiological dysfunction in sickle cell anemia (SCA). Copper (Cu) is a
prooxidant, whereas zinc (Zn) and selenium (Se) are antioxidant trace elements. This study investigates the serum levels of Cu, Zn, and
Se among children with SCA.
Materials and methods: This cross-sectional study was performed at King Khalid University Hospital, Riyadh. Thirty-three children
with SCA in steady state and 33 age- and sex-matched normal healthy children were included in the study. Cu, Zn, and Se levels were
measured by inductively coupled plasma-mass spectrometry (ICP-MS) instrument.
Results: The median serum Cu levels among SCA patients (1.3 μg/mL) were higher than those of the controls (0.88 μg/mL; P < 0.0001).
Zn (0.61 μg/mL) and Se (74 ng/mL) levels among SCA patients, however, were significantly lower than those of the controls (0.94 μg/
mL; P < 0.0001) and (91.2 ng/mL; P < 0.0001), respectively. The Cu/Zn ratio among SCA patients (1.92) was higher than that of the
controls (0.98).
Conclusion: Decreased blood levels of antioxidant trace elements may contribute to the pathophysiology in SCA by promoting oxidative
stress. The monitoring of trace element levels in SCA appears to be vital for decreasing morbidity associated with the disorder.
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1. Introduction
Sickle cell anemia (SCA) is a hemoglobinopathy that
manifests in infancy and is associated with shortened life
expectancy due to repeated episodes of acute illness and
organ damage [1]. It is characterized by a predominant
presence of sickle hemoglobin (HbS) resulting from a
substitution of glutamic acid to valine at sixth amino
acid position in the β globin chain [2]. HbS is inherently
unstable and tends to polymerize under low oxygen
tension resulting in sickling of red blood cells, hemolysis,
and anemia [3]. Sickling and hemolysis in SCA are
associated with a high level of oxidative stress due to
increased production of superoxide anion, reactive oxygen
species (ROS), and impaired activity of ROS-scavenging
enzymes [4]. Low level of ROS activity has been attributed
to inadequate vitamin intake or decreased production of
enzymes due to cofactors deficiency [5].
Copper (Cu) and zinc (Zn) as cofactors are essential for
the optimal performance of superoxide dismutase (SOD),
an ROS scavenging enzyme responsible for handling
superoxide radicals, thus preventing tissue damage [6,7].

Zn as a trace element behaves as antioxidant [8], whereas
Cu is a prooxidant [9]. SCA patients are more susceptible to
alterations in these trace element concentrations because of
preexisting oxidative stress due to accelerated autooxidation
of HbS [10]. Selenium (Se) is essential for a wide variety
of cellular functions. Human selenoprotenome comprised
of 25 separate genes encodes for selenoproteins, including
glutathione peroxidase, a member of ROS scavenging
enzymes [11]. Se acts as an antioxidant and plays a crucial
role in the defense against oxidative stress [12]. Although a
number of investigations have assessed oxidative stress in
SCA, the data regarding the status of anti- and prooxidant
trace elements among patients with SCA are insufficient,
particularly in the Kingdom of Saudi Arabia. This study
was performed at King Khalid University Hospital, Riyadh,
with the aim to assess serum levels of Cu, Zn, and Se among
children with SCA in steady state.
2. Materials and methods
This cross-sectional study was performed in the Clinical
Chemistry Unit at King Khalid University Hospital,
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Riyadh, between July 2015 and September 2016. A total of
33 patients with SCA were recruited from the hematology
clinic at King Khalid University Hospital, Riyadh, Kingdom
of Saudi Arabia. The diagnosis of SCA was confirmed by
hemoglobin electrophoresis. Prior to enrollment in the
study, it was ensured that none of the participants was
receiving trace element supplements either at the time
of enrollment or at least three months prior. Any patient
with β- or α-thalassemia trait, G6PD deficiency, receiving
treatment with hydroxyurea, receiving blood transfusion
less than one month prior to enrollment, and presence
of any chronic illness other than the primary disease
was excluded from the study. After obtaining informed
consent, 5 mL of venous blood were collected aseptically in
a vacutainer without anticoagulant. Serum was separated
from each sample by centrifugation and was stored at –80
°C until used. Cu, Zn, and Se levels were measured by
inductively coupled plasma-mass spectrometry (ICP-MS)
instrument (Perkin-Elmer, Warsaw, Poland). This study
was approved by the Institutional Review Board (IRB) of
the College of Medicine, King Saud University, Riyadh,
Kingdom of Saudi Arabia. Reference number: 15/0292/
IRB. Project number: E-15-1380. All participants/parents
provided informed consent prior to inclusion in the study.
2.1. Statistical analysis
Data were analyzed by MedCalc computer software,
version 14.8.1. Categorical data were summarized as
numbers and percentages. Numeric data were summarized
as means and standard deviations, or medians and
interquartile ranges. Comparison between groups for
categorical markers was performed using the chi-square
test or Fisher’s exact test. Comparisons between groups

for continuous variables were done by using independent
sample t-test or the Mann–Whitney U test. P < 0.05 was
considered statistically significant.
3. Results
Thirty-three children with SCA (19 males and 14 females;
mean age 8.5 ± 4.1 years) of consenting parents were
included in the study. A group of 33 healthy children
(18 males and 15 females; mean age 7.3 ± 3.7 years) was
also included in the study as normal controls. Patients
with SCA had low mean hemoglobin level of 91.3 ± 8.1
g/L compared to controls (139.7 ± 6.2; P < 0.001). The
mean HbS percentage among children with SCA was
86.6 ± 7.1%, whereas none of the controls had HbS. HBA2
among children with SCA (3.4 ± 2.4%) was not different
from that of the controls (2.8 ± 1.3%). Mean percentage
of HBF (10.1 ± 5%) among children with SCA was
higher than controls (1.9 ± 0.8%; P < 0.005) (Table). Data
comparing serum levels of Cu between patients with SCA
and normal controls are shown in Figure 1. The median
serum level of Cu among patients with SCA (1.3 μg/mL)
was significantly higher than in normal controls (0.88
μg/mL; P < 0.0001). Figure 2 compares serum levels of
Zn between patients with SCA and controls. The median
level of Zn among the patients with SCA (0.61 μg/mL) was
significantly lower than that in normal controls (0.94 μg/
mL; P < 0.0001). Figure 3 shows the data for serum levels
of Se among patients with SCA and controls. The median
serum level of Se (74 ng/mL) among patients with SCA
was significantly lower than that in normal controls (91.2
ng/mL; P < 0.0001). Cu to Zn ratio (Cu/Zn) among the
control group was 0.98, whereas Cu/Zn among children
with SCA was 1.92.

Table. Characteristic features of children with sickle cell anemia (SCA) and normal controls.
Parameter

Patients with SCA

Normal controls

P-value

Age (years)

8.5 ± 4.1

7.3 ± 3.7

0.21

Males, n (%)

19 (57.5%)

18 (54.5%)

0.803

Females, n (%)

14 (42.4%)

15 (45.4%)

0.803

Male/female ratio

1.3

1.2

-

Hemoglobin (g/L)

91.3 ± 8.1

139.7 ± 6.2

0.001

Hemoglobin S%

86.6 ± 7.1

None

-

Hemoglobin A2%

3.4 ± 2.4

2.8 ± 1.3

0.09

Hemoglobin F%

10.1 ± 5

1.9 ± 0.8

0.005

Hemoglobin A%

None

97.1 ± 0.7

-

Painful episodes / year

4.3 ± 2.7

None

-

Infections / year

5.1 ± 1.7

2.3 ± 1.7

0.02

Patients with SCA: n = 33; normal controls: n = 33
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Figure 1. Comparison of serum copper levels between patients
with SCA and normal controls. *P < 0.0001
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Figure 2. Comparison of serum zinc levels between patients with
SCA and normal controls. *P< 0.0001
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Figure 3. Comparison of serum selenium levels between patients
with SCA and normal controls. *P < 0.0001

4. Discussion
Children with SCA had elevated serum Cu levels, whereas
serum levels of Zn and Se were significantly lower than
those in controls. High levels of serum Cu among SCA
patients have been reported previously [13]. Free Cu
ions promote the production of reactive hydroxy radicals
and may therefore contribute to prooxidant activity in
SCA [14]. The availability of free Cu ions is facilitated by
concentrations of Cu higher than the binding capacity of
ceruloplasmin serving as an antioxidant [15]. Increased
urinary loses of Zn among patients with SCA [16] may
also contribute to higher Cu levels and increased Cu/
Zn ratio, as observed in the present study. Moreover, the
higher amount of zincuria among SCA patients, by causing
Zn deficiency, triggers enhanced Cu absorption from the
gastrointestinal tract that may have contributed to elevated
serum Cu levels [17]. Collectively, the evidence suggests
that among patients with SCA, the Cu and Zn homeostasis
is skewed in favor of prooxidant activity.
The serum levels of Zn were significantly lower among
SCA patients compared to those of controls in the present
study. Elevated levels of copper and low levels of Zn
among patients with SCA have been reported previously
[18], indicating a compromised status of defense against
oxidative stress. Zn supplementation among patients
with SCA not only restores antioxidant reserves, but
also decreases the incidence of infections with increased
hemoglobin and hematocrit levels [19]. Restoration of
serum Zn levels not only markedly reduces the tendency
for sickling of red blood cells but is also associated with
a remarkable reduction in the incidence of vaso-occlusive
events among SCA patients [20,21]. Zn deficiency has been
implicated in a number of immune abnormalities [22].
Supplementation of Zn in patients with SCA has also been
shown to restore impaired delayed type of hypersensitivity
reaction and abnormalities in natural killer cell function
[19]. The diversity of abnormalities described among SCA
patients [22] may be linked directly or indirectly with Zn
deficiency, as Zn has been shown to be an essential cofactor
for over 300 enzymes [23].
SCA patients in the present study had a higher Cu/
Zn ratio compared to normal controls. Increased Cu/
Zn ratio has been documented in SCA previously and is
considered a useful adjunct for the diagnosis of SCA [24].
Successful treatment of hyperglycemia with resveratrol in
type 2 diabetes mellitus is associated with a remarkable
reduction in oxidative stress along with decreased Cu/Zn
ratio due to the lowering of serum Cu levels [25]. These
findings indicate that the assessment of Cu/Zn ratio may
serve as a useful tool for gauging oxidative stress. Periodic
assessment of Cu/Zn ratio among SCA patients, therefore,
appears to be useful not only for monitoring oxidative
stress among these patients, but may also preempt an
impending sickle cell crisis.
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Compared to normal controls, serum levels of Se were
significantly lower among SCA patients in the present
study. Though infrequently, low blood levels of Se have
been reported among patients with SCA [26], suggesting
a weak antioxidant potential. The antiinflammatory role of
Se was recently demonstrated in an experimental study on
adiponectin knockout mice where Se was shown to provide
protection against chronic inflammation-induced colon
cancer [27]. Selenoproteins are Se containing proteins
mediating biological effects of Se [28]. Glutathione
peroxidases are selenoproteins and are the main
antioxidants involved in neutralizing the production of ROS
[29]. Low levels of glutathione peroxidase among patients
with SCA [26] highlights the importance of Se in handling
the oxidative stress associated with SCA. In addition, Se
has been shown to provide protection against oxidative

stress-induced lipid peroxidation and disturbances in fatty
acid biosynthesis among patients with SCA [30].
In conclusion, children with SCA had low levels of
Zn and Se with elevated serum levels of Cu. Decreased
blood levels of antioxidant trace elements may contribute
to the pathophysiology in SCA by promoting oxidative
stress. The monitoring of trace element levels in SCA
appears to be important for reduction in disease associated
morbidity among children with SCA. Large-scale studies
are recommended to validate the findings of this study and
further elucidate the role of trace elements in sickle cell
disease.
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